Document Detail


Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.
MedLine Citation:
PMID:  19569969     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Practice guidelines for therapeutic monitoring of vancomycin treatment for Staphylococcus aureus infection in adult patients were reviewed by an expert panel of the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. A literature review of existing evidence regarding vancomycin dosing and monitoring of serum concentrations, in addition to patient outcomes combined with expert opinion regarding the drug's pharmacokinetic, pharmacodynamic, and safety record, resulted in new recommendations for targeting and adjustment of vancomycin therapy.
Authors:
Michael J Rybak; Ben M Lomaestro; John C Rotschafer; Robert C Moellering; Willam A Craig; Marianne Billeter; Joseph R Dalovisio; Donald P Levine
Related Documents :
19528049 - Our plastic age.
19800249 - Training, certification and practice of cardiac and thoracic surgeons in europe: a comp...
20346339 - Diversity in membership and leadership positions in a regional vascular society.
20827649 - [comment on the s3 guidelines dementia by the dgppn and the dgn from the neurological p...
21114069 - A twentieth-century triangle trade: selling black beauty at home and abroad, 1945–1965.
20506459 - An updated history of the teratology society.
10803559 - Evolution and coordination of the alternative methods in spain
21452989 - Conference report: the 1st conference in asia-pacific on recent issues in bioanalysis.
7917749 - An anaesthetic minimum dataset and report format. society for computing and technology ...
Publication Detail:
Type:  Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America     Volume:  49     ISSN:  1537-6591     ISO Abbreviation:  Clin. Infect. Dis.     Publication Date:  2009 Aug 
Date Detail:
Created Date:  2009-07-09     Completed Date:  2009-08-31     Revised Date:  2010-07-26    
Medline Journal Info:
Nlm Unique ID:  9203213     Medline TA:  Clin Infect Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  325-7     Citation Subset:  IM    
Affiliation:
Anti-Infective Research Laboratory, Department of Pharmacy Practice, College of Pharmacy & Health Sciences, Wayne State University, Detroit Receiving Hospital & University Health Center, Detroit, Michigan 48201, USA. m.rybak@wayne.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anti-Bacterial Agents / administration & dosage,  adverse effects,  pharmacokinetics,  therapeutic use*
Humans
Staphylococcal Infections / drug therapy*,  microbiology
Staphylococcus aureus / drug effects*
Treatment Outcome
Vancomycin / administration & dosage,  adverse effects,  pharmacokinetics,  therapeutic use*
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 1404-90-6/Vancomycin
Comments/Corrections
Comment In:
Clin Infect Dis. 2009 Dec 15;49(12):1964-5; author reply 1965   [PMID:  19929398 ]
Clin Infect Dis. 2010 Feb 15;50(4):616-7   [PMID:  20095837 ]
Clin Infect Dis. 2010 Feb 15;50(4):616   [PMID:  20095836 ]
Erratum In:
Clin Infect Dis. 2009 Nov 1;49(9):1465

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Large-scale adeno-associated viral vector production using a herpesvirus-based system enables manufa...
Next Document:  Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of...